NAMS — NewAmsterdam Pharma Co N.V. catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

3 verified catalyst event(s) for NewAmsterdam Pharma Co N.V. (ticker NAMS). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-09-01 — Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of Healthy Vol · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-09 (month) in 2mo ESTIMATED	READOUT Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of H Phase 2 · Antioxidant Absorption	NAMS NewAmsterdam Pharma Co N.V.	Obicetrapib 10mg	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-11 (month) in 4mo ESTIMATED	READOUT Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients W Phase 3 · Atherosclerotic Cardiovascular Disease	NAMS NewAmsterdam Pharma Co N.V.	Obicetrapib	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-11 (month) in 4mo ESTIMATED	READOUT Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels Phase 2 · Dyslipidemias	NAMS NewAmsterdam Pharma Co N.V.	obicetrapib 10 mg + obicetrapib/evolocum	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change